BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 38643464)

  • 1. Treatment patterns and survival in T4b esophageal cancer: a retrospective cohort study.
    Yu BB; Huang JQ; Liang HW; Liu Y; Chen L; Pei S; Huang W; Pan XB
    Aging (Albany NY); 2024 Apr; 16(8):7131-7140. PubMed ID: 38643464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concurrent chemoradiotherapy with or without surgery for patients with resectable esophageal cancer: An analysis of the National Cancer Data Base.
    Naik KB; Liu Y; Goodman M; Gillespie TW; Pickens A; Force SD; Steuer CE; Owonikoko TK; Ramalingam SS; Higgins K; Beitler JJ; Shin DM; Willingham FF; El-Rayes B; Landry JC; Fernandez FG; Saba NF
    Cancer; 2017 Sep; 123(18):3476-3485. PubMed ID: 28464264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does surgery improve outcomes for esophageal squamous cell carcinoma? An analysis using the surveillance epidemiology and end results registry from 1998 to 2008.
    Worni M; Martin J; Gloor B; Pietrobon R; D'Amico TA; Akushevich I; Berry MF
    J Am Coll Surg; 2012 Nov; 215(5):643-51. PubMed ID: 23084493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of Perioperative Chemotherapy in Lymph Node-negative Esophageal Cancer After Resection: A Population-based Study With Propensity Score-matched Analysis.
    Yang Y; Zhou X; Tang L; Xu X; Du X; Qiu G
    Am J Clin Oncol; 2019 Dec; 42(12):924-931. PubMed ID: 31651453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of surgery plus chemoradiotherapy on survival of elderly patients with stage Ⅱ-Ⅲ esophageal cancer: a SEER-based demographic analysis.
    Lv H; Chao C; Wang B; Wang Z; Qian Y; Zhang X
    Cancer Med; 2021 Dec; 10(23):8483-8496. PubMed ID: 34800005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison Between Esophagectomy and Definitive Chemoradiotherapy in Patients With Esophageal Cancer.
    Wang BY; Hung WH; Wu SC; Chen HC; Huang CL; Lin CH; Chen HS
    Ann Thorac Surg; 2019 Apr; 107(4):1060-1067. PubMed ID: 30571951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment modalities for T1N0 esophageal cancers: a comparative analysis of local therapy versus surgical resection.
    Berry MF; Zeyer-Brunner J; Castleberry AW; Martin JT; Gloor B; Pietrobon R; D'Amico TA; Worni M
    J Thorac Oncol; 2013 Jun; 8(6):796-802. PubMed ID: 24614244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment Modalities for Esophageal Adenocarcinoma in the United States: Trends and Survival Outcomes.
    Di Corpo M; Schlottmann F; Strassle PD; Nurczyk K; Patti MG
    J Laparoendosc Adv Surg Tech A; 2019 Aug; 29(8):989-994. PubMed ID: 31246532
    [No Abstract]   [Full Text] [Related]  

  • 9. Patterns of recurrence after surgery and efficacy of salvage therapy after recurrence in patients with thoracic esophageal squamous cell carcinoma.
    Ni W; Yang J; Deng W; Xiao Z; Zhou Z; Zhang H; Chen D; Feng Q; Liang J; Lv J; Wang X; Wang X; Zhang T; Bi N; Deng L; Wang W
    BMC Cancer; 2020 Feb; 20(1):144. PubMed ID: 32087687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of Unresectable T4b Esophageal Cancer: Practice Patterns and Outcomes From the National Cancer Data Base.
    Cushman TR; Shaaban SG; Moreno AC; Lin C; Verma V
    Am J Clin Oncol; 2019 Feb; 42(2):154-159. PubMed ID: 30499838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trends and outcomes in the use of surgery and radiation for the treatment of locally advanced esophageal cancer: a propensity score adjusted analysis of the surveillance, epidemiology, and end results registry from 1998 to 2008.
    Worni M; Castleberry AW; Gloor B; Pietrobon R; Haney JC; D'Amico TA; Akushevich I; Berry MF
    Dis Esophagus; 2014; 27(7):662-9. PubMed ID: 23937253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Palliative resection or radiation of primary tumor prolonged survival for metastatic esophageal cancer.
    Xu J; Lu D; Zhang L; Li J; Sun G
    Cancer Med; 2019 Dec; 8(17):7253-7264. PubMed ID: 31612596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Definitive Chemoradiotherapy Compared to Neoadjuvant Chemoradiotherapy With Esophagectomy for Locoregional Esophageal Cancer: National Population-based Cohort Study.
    Kamarajah SK; Phillips AW; Hanna GB; Low D; Markar SR
    Ann Surg; 2022 Mar; 275(3):526-533. PubMed ID: 32865948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment and survival outcomes of small cell carcinoma of the esophagus: an analysis of the National Cancer Data Base.
    Wong AT; Shao M; Rineer J; Osborn V; Schwartz D; Schreiber D
    Dis Esophagus; 2017 Feb; 30(2):1-5. PubMed ID: 27860114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trends in treatment and overall survival among patients with proximal esophageal cancer.
    de Vos-Geelen J; Geurts SM; van Putten M; Valkenburg-van Iersel LB; Grabsch HI; Haj Mohammad N; Hoebers FJ; Hoge CV; Jeene PM; de Jong EJ; van Laarhoven HW; Rozema T; Slingerland M; Tjan-Heijnen VC; Nieuwenhuijzen GA; Lemmens VE
    World J Gastroenterol; 2019 Dec; 25(47):6835-6846. PubMed ID: 31885424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of Clinical T1N0M0 Esophageal Cancer.
    Yang AJ; Choi SH; Byun HK; Kim HJ; Choi J; Lee YC; Lee SK; Park KR; Lee CG
    Gut Liver; 2019 May; 13(3):315-324. PubMed ID: 30600672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved prognosis with induction chemotherapy in pathological complete responders after trimodality treatment for esophageal squamous cell carcinoma: Hypothesis generating for adjuvant treatment.
    Lu SL; Hsu FM; Tsai CL; Lee JM; Huang PM; Hsu CH; Lin CC; Chang YL; Hsieh MS; Cheng JC
    Eur J Surg Oncol; 2019 Aug; 45(8):1498-1504. PubMed ID: 30910457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison between surgery and definitive chemoradiotherapy for patients with resectable esophageal squamous cell carcinoma: a propensity score analysis.
    Nomura M; Oze I; Kodaira T; Abe T; Komori A; Narita Y; Masuishi T; Taniguchi H; Kadowaki S; Ura T; Andoh M; Tachibana H; Uemura N; Tajika M; Niwa Y; Muto M; Muro K
    Int J Clin Oncol; 2016 Oct; 21(5):890-898. PubMed ID: 26980212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Consequences of Refusing Surgery for Esophageal Cancer: A National Cancer Database Analysis.
    Rahouma M; Harrison S; Kamel M; Nasar A; Lee B; Port J; Altorki N; Stiles B
    Ann Thorac Surg; 2018 Nov; 106(5):1476-1483. PubMed ID: 30055137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemoradiotherapy before and after surgery for locally advanced esophageal cancer: a SEER-Medicare analysis.
    Hong JC; Murphy JD; Wang SJ; Koong AC; Chang DT
    Ann Surg Oncol; 2013 Nov; 20(12):3999-4007. PubMed ID: 23800897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.